125 related articles for article (PubMed ID: 36395579)
1. Total Tumor Load to assist in the decision for additional axillary surgery in the positive sentinel node breast cancer patients.
Sousa N; Peleteiro B; Fougo JL
Surg Oncol; 2022 Dec; 45():101882. PubMed ID: 36395579
[TBL] [Abstract][Full Text] [Related]
2. Intraoperative Molecular Analysis of Total Tumor Load in Sentinel Lymph Node: A Predictor of Axillary Status in Early Breast Cancer.
Laohawiriyakamol S; Mahattanobon S; Puttawibul P
Asian Pac J Cancer Prev; 2022 Jan; 23(1):349-354. PubMed ID: 35092404
[TBL] [Abstract][Full Text] [Related]
3. Total tumor load assessed by one-step nucleic acid amplification assay as an intraoperative predictor for non-sentinel lymph node metastasis in breast cancer.
Nabais C; Figueiredo J; Lopes P; Martins M; Araújo A
Breast; 2017 Apr; 32():33-36. PubMed ID: 28030783
[TBL] [Abstract][Full Text] [Related]
4. Value of total tumor load as a clinical and pathological factor in the prognosis of breast cancer patients receiving neoadjuvant treatment. Comparison of three populations with three different surgical approaches: NEOVATTL Pro 3 Study.
Martín-Salvago MD; Sancho M; López-García MÁ; Cano Jiménez A; Pérez-Luque A; Alfaro L; Vieites B
Breast Cancer Res Treat; 2023 Jul; 200(2):203-215. PubMed ID: 37219637
[TBL] [Abstract][Full Text] [Related]
5. Intraoperative molecular analysis of total tumor load in sentinel lymph node: a new predictor of axillary status in early breast cancer patients.
Peg V; Espinosa-Bravo M; Vieites B; Vilardell F; Antúnez JR; de Salas MS; Delgado-Sánchez JJ; Pinto W; Gozalbo F; Petit A; Sansano I; Del Mar Téllez M; Rubio IT
Breast Cancer Res Treat; 2013 May; 139(1):87-93. PubMed ID: 23576079
[TBL] [Abstract][Full Text] [Related]
6. Prediction of non-sentinel lymph node metastasis in early breast cancer by assessing total tumoral load in the sentinel lymph node by molecular assay.
Espinosa-Bravo M; Sansano I; Pérez-Hoyos S; Ramos M; Sancho M; Xercavins J; Rubio IT; Peg V
Eur J Surg Oncol; 2013 Jul; 39(7):766-73. PubMed ID: 23607911
[TBL] [Abstract][Full Text] [Related]
7. Nomogram to predict non-sentinel lymph node status using total tumor load determined by one-step nucleic acid amplification: first report from Thailand.
Sa-Nguanraksa D; O-Charoenrat E; Kulprom A; Samarnthai N; Lohsiriwat V; Nimpoonsri K; O-Charoenrat P
Breast Cancer; 2019 Jul; 26(4):471-477. PubMed ID: 30617675
[TBL] [Abstract][Full Text] [Related]
8. Trade-offs associated with axillary lymph node dissection with breast irradiation versus breast irradiation alone in patients with a positive sentinel node in relation to the risk of non-sentinel node involvement: implications of ACOSOG Z0011.
Krishnan MS; Recht A; Bellon JR; Punglia RS
Breast Cancer Res Treat; 2013 Feb; 138(1):205-13. PubMed ID: 23338762
[TBL] [Abstract][Full Text] [Related]
9. Intraoperative prediction of the two axillary lymph node macrometastases threshold in patients with breast cancer using a one-step nucleic acid cytokeratin-19 amplification assay.
Fung V; Kohlhardt S; Vergani P; Zardin GJ; Williams NR
Mol Clin Oncol; 2017 Nov; 7(5):755-762. PubMed ID: 29142748
[TBL] [Abstract][Full Text] [Related]
10. Omitting axillary lymph node dissection after positive sentinel lymph node in the post-Z0011 era: Compliance with NCCN and ASCO clinical guidelines and Z0011 criteria in a large prospective cohort.
Costaz H; Boulle D; Bertaut A; Rouffiac M; Beltjens F; Desmoulins I; Peignaux K; Ladoire S; Causeret S; Loustalot C; Padeano MM; Vincent L; Jankowski C; Arnould L; Coutant C
Bull Cancer; 2022 Mar; 109(3):268-279. PubMed ID: 34838310
[TBL] [Abstract][Full Text] [Related]
11. A cut-off of 2150 cytokeratin 19 mRNA copy number in sentinel lymph node may be a powerful predictor of non-sentinel lymph node status in breast cancer patients.
Terrenato I; D'Alicandro V; Casini B; Perracchio L; Rollo F; De Salvo L; Di Filippo S; Di Filippo F; Pescarmona E; Maugeri-Saccà M; Mottolese M; Buglioni S
PLoS One; 2017; 12(2):e0171517. PubMed ID: 28187209
[TBL] [Abstract][Full Text] [Related]
12. Role of total tumour load of sentinel lymph node on survival in early breast cancer patients.
Peg V; Sansano I; Vieites B; Bernet L; Cano R; Córdoba A; Sancho M; Martín MD; Vilardell F; Cazorla A; Espinosa-Bravo M; Pérez-García JM; Cortés J; Rubio IT; Ramón Y Cajal S
Breast; 2017 Jun; 33():8-13. PubMed ID: 28254641
[TBL] [Abstract][Full Text] [Related]
13. Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases: Long-term Follow-up From the American College of Surgeons Oncology Group (Alliance) ACOSOG Z0011 Randomized Trial.
Giuliano AE; Ballman K; McCall L; Beitsch P; Whitworth PW; Blumencranz P; Leitch AM; Saha S; Morrow M; Hunt KK
Ann Surg; 2016 Sep; 264(3):413-20. PubMed ID: 27513155
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer metastasis burden in sentinel nodes analysed using one-step nucleic acid amplification predicts axillary nodal status.
Milner TD; de Lusignan S; Jones S; Jackson PA; Layer GT; Kissin MW; Irvine TE
Breast; 2015 Oct; 24(5):568-75. PubMed ID: 26032111
[TBL] [Abstract][Full Text] [Related]
15. The impact of axillary ultrasound with biopsy in overtreatment of early breast cancer.
Del Riego J; Diaz-Ruiz MJ; Teixidó M; Ribé J; Vilagran M; Canales L; Sentís M;
Eur J Radiol; 2018 Jan; 98():158-164. PubMed ID: 29279156
[TBL] [Abstract][Full Text] [Related]
16. Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial.
Giuliano AE; Ballman KV; McCall L; Beitsch PD; Brennan MB; Kelemen PR; Ollila DW; Hansen NM; Whitworth PW; Blumencranz PW; Leitch AM; Saha S; Hunt KK; Morrow M
JAMA; 2017 Sep; 318(10):918-926. PubMed ID: 28898379
[TBL] [Abstract][Full Text] [Related]
17. Changes in utilization of axillary dissection in women with invasive breast cancer and sentinel node metastasis after the ACOSOG Z0011 trial.
Tseng J; Alban RF; Siegel E; Chung A; Giuliano AE; Amersi FF
Breast J; 2021 Mar; 27(3):216-221. PubMed ID: 33586201
[TBL] [Abstract][Full Text] [Related]
18. Predictive and prognostic value of total tumor load in sentinel lymph nodes in breast cancer patients after neoadjuvant treatment using one-step nucleic acid amplification: the NEOVATTL study.
Vieites B; López-García MÁ; Martín-Salvago MD; Ramirez-Tortosa CL; Rezola R; Sancho M; López-Vilaró L; Villardell F; Burgués O; Fernández-Rodriguez B; Alfaro L; Peg V
Clin Transl Oncol; 2021 Jul; 23(7):1377-1385. PubMed ID: 33517542
[TBL] [Abstract][Full Text] [Related]
19. Preoperative predictors of high and low axillary nodal burden in Z0011 eligible breast cancer patients with a positive lymph node needle biopsy result.
Lim GH; Upadhyaya VS; Acosta HA; Lim JMA; Allen JC; Leong LCH
Eur J Surg Oncol; 2018 Jul; 44(7):945-950. PubMed ID: 29705286
[TBL] [Abstract][Full Text] [Related]
20. Staging of women with breast cancer after introduction of sentinel node guided axillary dissection.
Tvedskov TF
Dan Med J; 2012 Jul; 59(7):B4475. PubMed ID: 22759850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]